The international workshop on meibomian gland dysfunction: Report of the definition and classification subcommittee

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 4, 2011, Pages 1930-1937

  Daniel Nelson, J ^a   Shimazaki, Jun ^b   Benitez del Castillo, Jose M ^c   Craig, Jennifer ^d   McCulley, James P ^e   Den, Seika ^b   Foulks, Gary N ^f  

^a Health Partners Medical Group   (United States)

^b TOKYO DENTAL COLLEGE   (Japan)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMICROSCOPY; BLEPHARITIS; CHRONIC DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRY EYE; EYE DISEASE; EYE INFLAMMATION; EYE IRRITATION; EYELID DISEASE; HUMAN; KERATOCONJUNCTIVITIS; MEIBOMIAN GLAND; MEIBOMIAN GLAND DYSFUNCTION; NATIONAL HEALTH ORGANIZATION; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; SEBUM SECRETION; SLIT LAMP; TEAR FILM; WORKSHOP;

EYELID DISEASES; HUMANS; LACRIMAL DUCT OBSTRUCTION; MEIBOMIAN GLANDS; TERMINOLOGY AS TOPIC;

EID: 79953757700     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6997b     Document Type: Article

References (45)

1. Mathers WD. Ocular evaporation in meibomian gland dysfunction and dry eye. Ophthalmology. 1993;100:347-351.
2. Mathers WD, Lane JA. Meibomian gland lipids, evaporation, and tear film stability. Adv Exp Med Biol. 1998;438:349-360.
3. Shimazaki J, Sakata M, Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol. 1995;113:1266-1270
4. Lee SH, Tseng SC. Rose bengal staining and cytologic characteristics associated with lipid tear deficiency. Am J Ophthalmol. 1997; 124:736-750.
5. Yokoi N, Mossa F, Tiffany JM, Bron AJ. Assessment of meibomian gland function in dry eye using meibometry. Arch Ophthalmol. 1999;117:723-729.
6. Goto E, Monden Y, Takano Y, et al. Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compression device. Br J Ophthalmol. 2002;86:1403-1407.
7. Foulks GN, Bron AJ. Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf. 2003;1:107-126.
8. Matsumoto Y, Dogru M, Goto E, et al. Efficacy of a new warm moist air device on tear functions of patients with simple meibomian gland dysfunction. Cornea. 2006;25:644-650.
9. Matsumoto Y, Sato EA, Ibrahim OM, Dogru M, Tsubota K. The application of in vivo laser confocal microscopy to the diagnosis and evaluation of meibomian gland dysfunction. Mol Vis. 2008;14: 1263-1271.
10. Arita R, Itoh K, Maeda S, et al. Proposed diagnostic criteria for obstructive meibomian gland dysfunction. Ophthalmology. 2009; 116:2058-2063.
11. Amano S. MGD Working Group: Definition and diagnostic criteria for meibomian gland dysfunction. J Eye (Atarashii Ganka). 2010; 27:627-631.
12. Wulc A, Dryden R, Khatchaturian T. Where is the gray line? Arch Ophthalmol. 1987;105:1092-1098.
13. Rolando M, Papadia M. Diagnosis and management of the lid and ocular surface disorders. In: Asbell P, Lemp M, eds. Dry Eye Disease: The Clinician's Guide to Diagnosis and Treatment. New York: Thieme Medical Publishers; 2006:71.
14. Gutgesell VJ, Stern GA, Hood CI. Histopathology of meibomian gland dysfunction. Am J Ophthalmol. 1982;94:383-387.
15. Keith C. Seborrheic blepharo-kerato-conjunctivitis. Trans Oph-thalmol Soc UK. 1967;87:85-103.
16. McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology. 1982;89:1173-1180.
17. Luchs J. Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis. Adv Ther. 2008;25:858-870.
18. McCulley JP, Sciallis GF. Meibomian keratoconjunctivitis. Am J Ophthalmol. 1977;84:788-793.
19. Mathers W. Meibomian gland disease. In: Pflugfelder S, Beuerman R, Stern M, eds. Dry Eye and Ocular Surface Disorders. New York: Marcel Dekker, Inc.; 2004:255.
20. Duke-Elder W, MacFaul P. The ocular adnexa, Part 1: inflammations of the lid margins. In: Duke-Elder W, MacFaul P, eds. System of Ophthalmology. London: H. Kimpron; 1974:205-250.
21. Goto E, Shimazaki J, Monden Y, et al. Low-concentration homogenized castor oil eye drops for noninflamed obstructive meibo-mian gland dysfunction. Ophthalmology. 2002;109:2030-2035.
22. Korb DR, Henriquez AS. Meibomian gland dysfunction and contact lens intolerance. J Am Optom Assoc. 1980;51:243-251.
23. Jester J, Nicolaides N, Smith RE. Meibomian gland studies: histo-logic and ultrastructural investigations. Invest Ophthalmol Vis Sci. 1981;20:537-547.
24. Jester JV, Rife L, Nii D, Luttrull JK, Wilson L, Smith RE. In vivo biomicroscopy and photography of meibomian glands in a rabbit model of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 1982;22:660-667.
25. Bron AJ, Benjamin L, Snibson GR. Meibomian gland disease: classification and grading of lid changes. Eye. 1991;5:395-411.
26. Naldi L, Rebora A. Seborrheic dermatitis. N Engl J Med. 2009;360: 387-396.
27. Bron AJ, Tiffany JM. The contribution of meibomian disease to dry eye. Ocul Surf. 2004;2:149-164.
28. Begley C, Chalmers R, Abetz L, et al. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci. 2003;44:4753-4761.
29. Mathers WD, Shields WJ, Sachdev MS, Petroll WM, Jester JV. Meibomian gland dysfunction in chronic blepharitis. Cornea. 1991;10:277-285.
30. Mathers WD, Billborough M. Meibomian gland function and giant papillary conjunctivitis. Am J Ophthalmol. 1992;114:188-192.
31. Shimazaki J, Goto E, Ono M, Shimmura S, Tsubota K. Meibomian gland dysfunction in patients with Sjogren syndrome. Ophthalmology. 1998;105:1485-1488.
32. Obata H, Horiuchi H, Miyata K, Tsuru T, Machinami R. Histopatho-logical study of the meibomian glands in 72 autopsy cases (in Japanese). Nippon Ganka Gakkai Zasshi. 1994;98:765-771.
33. Hykin PG, Bron AJ. Age-related morphological changes in lid margin and meibomian gland anatomy. Cornea. 1992;11:334-342.
34. Gifford S. Meibomian glands in chronic blepharoconjunctivitis. Am J Ophthalmol. 1921;4:489-494.
35. Arita R, Itoh K, Inoue K, Kuchiba A, Yamaguchi T, Amano S. Contact lens wear is associated with decrease of meibomian glands. Ophthalmology. 2009;116:379-384.
36. Landthaler M, Kummermehr J, Wagner A, Plewig G. Inhibitory effects of 13-cis-retinoic acid in human sebaceous glands. Arch Dermatol Res. 1980;269:297-309.
37. Sullivan B, Evans J, Cermak J, Krenzer K, Dana M, Sullivan D. Complete androgen insensitivity syndrome. Arch Ophthalmol. 2002;120:1689-1699.
38. Cunliffe W. Acne. London: Martin Dunitz; 1989.
39. Cunliffe W. The sebaceous gland and acne: 40 years on. Dermatology. 1998;196:9-15.
40. Pierard-Franchimont C, Pierard G, Saint-leger D, Leveque J, Kligman A. Comparison of the kinetics of sebum secretion in young women with and without acne. Dermatologica. 1991;183:120-122.
41. Shine WE, McCulley JP. Keratoconjunctivitis sicca associated with meibomian secretion polar lipid abnormality. Arch Ophthalmol. 1998;116:849-852.
42. Shine WE, McCulley JP. The role of cholesterol in chronic blepharitis. Invest Ophthalmol Vis Sci. 1991;32:2272-2280.
43. Shine WE, McCulley JP. Role of wax ester fatty alcohols in chronic blepharitis. Invest Ophthalmol Vis Sci. 1993;34:3515-3521.
44. Shine WE, McCulley JP. Polar lipids in human meibomian secretions. Curr Eye Res. 2003;26:89-94.
45. Craig J, Tomlinson A. Importance of the lipid layer in human tear film stability and evaporation. Optom Vis Sci. 1997;74:8-13.